首頁 › 前列腺癌 › 維吉尼亞州 › Charlottesville
Charlottesville, VA 的 前列腺癌 臨床試驗
15 項針對 前列腺癌 的研究正在 Charlottesville（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
The Vanguard Study: Testing a New Way to Screen for Cancer
招募中歡迎健康志工
- Sentara Martha Jefferson Hospital, Charlottesville
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
招募中3 期
- University of Virginia Health System ( Site 0054), Charlottesville
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
招募中3 期
- University of Virginia Comprehensive Cancer Center, Charlottesville
- University of Virginia, Charlottesville
- UVA Health Cancer Care Pantops, Charlottesville
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
招募中3 期
- University of Virginia Cancer Center, Charlottesville
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
招募中2 期
- University of Virginia Cancer Center, Charlottesville
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
招募中3 期
- University of Virginia Cancer Center, Charlottesville
FOG-001 in Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- University of Virginia, Charlottesville
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
招募中2 期
- University of Virginia Comprehensive Cancer Center, Charlottesville
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
招募中3 期
- University of Virginia Cancer Center, Charlottesville
HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)
招募中1/2 期
- University of Virginia, Charlottesville
A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer (Prostate 007)
招募中
- University of Virginia Health System, Charlottesville
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
招募中觀察性研究
- University of Virginia, Charlottesville
Remotely Monitored Exercise Interventions in Patients With mCSPC Undergoing ADT (Prostate 006)
招募中
- University of Virginia, Charlottesville
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
招募中1 期
- University of Virginia Cancer Center, Charlottesville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Charlottesville
其他城市的 前列腺癌 試驗
- New York City, NY103 項研究
- Houston, TX76 項研究
- Los Angeles, CA61 項研究
- Boston, MA59 項研究
- St. Louis, MO46 項研究
- Chicago, IL45 項研究
- San Francisco, CA45 項研究
- Philadelphia, PA44 項研究
- Baltimore, MD43 項研究
- Nashville, TN43 項研究
- Seattle, WA42 項研究
- Washington, DC38 項研究
Charlottesville 的其他研究
- 非小細胞肺癌21 項研究
- 急性髓系白血病16 項研究
- 癌症（所有類型）13 項研究
- 子宮內膜癌13 項研究
- 轉移性癌症13 項研究
- 肺癌13 項研究
- 心臟衰竭12 項研究
- 大腸直腸癌10 項研究
- 卵巢癌10 項研究
- 第一型糖尿病9 項研究
- 乳癌9 項研究
- 胰臟癌9 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。